Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1994 1
1999 1
2000 5
2001 3
2002 1
2003 5
2004 2
2005 3
2006 6
2007 3
2008 5
2009 7
2010 4
2011 7
2012 8
2013 13
2014 9
2015 12
2016 13
2017 6
2018 7
2019 9
2020 8
2021 10
2022 10
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Hypofractionated stereotactic irradiation for optic nerve glioma.
Zagirov RI, Trunin YY, Serova NK, Pronin IN, Antipina NA, Golanov AV. Zagirov RI, et al. Zh Vopr Neirokhir Im N N Burdenko. 2022;86(5):74-80. doi: 10.17116/neiro20228605174. Zh Vopr Neirokhir Im N N Burdenko. 2022. PMID: 36252196 English, Russian.
Optic nerve glioma is a rather rare tumor. It predominantly arises in pediatric patients, including those with type I neurofibromatosis. ...OBJECTIVE: To evaluate safety and efficacy of hypofractionated radiotherapy in patients with optic nerve …
Optic nerve glioma is a rather rare tumor. It predominantly arises in pediatric patients, including those with type I n …
Primary optic nerve tumours.
Wilhelm H. Wilhelm H. Curr Opin Neurol. 2009 Feb;22(1):11-8. doi: 10.1097/WCO.0b013e32831fd9f5. Curr Opin Neurol. 2009. PMID: 19155759 Review.
With a focus on the last few years' publications, recommendations for clinical management are being developed. RECENT FINDINGS: In low-grade optic nerve glioma, two divergent developments are observed: an increasing reluctance in treating such tumours …
With a focus on the last few years' publications, recommendations for clinical management are being developed. RECENT FINDINGS: In low-grade …
Neurological malignancies in neurofibromatosis type 1.
Eoli M, Saletti V, Finocchiaro G. Eoli M, et al. Curr Opin Oncol. 2019 Nov;31(6):554-561. doi: 10.1097/CCO.0000000000000576. Curr Opin Oncol. 2019. PMID: 31436563 Review.
PURPOSE OF REVIEW: The current review summarizes recent advances on three important issues in neurofibromatosis type 1 (NF1) management: the identification of specific NF1 gene mutations predicting the risk for developing neurological malignancies; the molecular features o …
PURPOSE OF REVIEW: The current review summarizes recent advances on three important issues in neurofibromatosis type 1 (NF1) management: the …
Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V, Rosca L, Samson Y, Ospina LH, Perreault S. Robert-Boire V, et al. Pediatr Neurol. 2017 Oct;75:55-60. doi: 10.1016/j.pediatrneurol.2017.06.019. Epub 2017 Jul 6. Pediatr Neurol. 2017. PMID: 28847625
CONCLUSIONS: Our cohort is one of the largest with OPGs and a detailed description of the clinical presentation both at diagnosis and at progression. We observed a significant difference between sporadic and NF1 optic pathway gliomas in terms of demographics, clinical pres …
CONCLUSIONS: Our cohort is one of the largest with OPGs and a detailed description of the clinical presentation both at diagnosis and at pro …
Neurofibromatosis: part 2--clinical management.
Batista PB, Bertollo EM, Costa Dde S, Eliam L, Cunha KS, Cunha-Melo JR, Darrigo Junior LG, Geller M, Gianordoli-Nascimento IF, Madeira LG, Mendes HM, Miranda DM, Mata-Machado NA, Morato EG, Pavarino ÉC, Pereira LB, Rezende NA, Rodrigues Lde O, Sette JB. Batista PB, et al. Arq Neuropsiquiatr. 2015 Jun;73(6):531-43. doi: 10.1590/0004-282X20150042. Arq Neuropsiquiatr. 2015. PMID: 26083891 Free article.
Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the onset or severity of new features, consequences, or complications make NF management a real clinical challenge, requiring the support of di …
Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the …
NEUROFIBROMATOSIS TYPE 1 AND OPTIC PATHWAY GLIOMA.
Siwá A, Autrata R, Vejmělková K, Pavelka Z, Zitterbart K. Siwá A, et al. Cesk Slov Oftalmol. 2019 Winter;75(4):200-208. doi: 10.31348/2019/4/4. Cesk Slov Oftalmol. 2019. PMID: 32397722 Free article. English.
Tumor progression itself does not always correlate with worse visual acuity outcomes, and it remains to be evaluated whether some patients would be better off without treatment. As of now, there are no clinical biomarkers able to predict impending visual acuity loss. CONCL …
Tumor progression itself does not always correlate with worse visual acuity outcomes, and it remains to be evaluated whether some patients w …
NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, Simmons I, Ferner R, Grill J, Hargrave D, Driever PH, Evans DG, Opocher E; SIOPE NF1 OPG Nottingham, UK, Workshop 2014. Azizi AA, et al. Neuro Oncol. 2021 Jan 30;23(1):100-111. doi: 10.1093/neuonc/noaa153. Neuro Oncol. 2021. PMID: 32628746 Free PMC article.
Treatment appeared to reduce tumor size but improved vision in only 10/45 treated patients. Children with visual deterioration after primary observation are more likely to improve with treatment than children treated at diagnosis. CONCLUSIONS: The analysis identified the i …
Treatment appeared to reduce tumor size but improved vision in only 10/45 treated patients. Children with visual deterioration after primary …
Optic pathway gliomas: a review.
Fried I, Tabori U, Tihan T, Reginald A, Bouffet E. Fried I, et al. CNS Oncol. 2013 Mar;2(2):143-59. doi: 10.2217/cns.12.47. CNS Oncol. 2013. PMID: 25057976 Free PMC article. Review.
Although optic pathway gliomas are low-grade tumors, their behavior can be aggressive, and their management is often challenging. Their management includes observation, surgery, chemotherapy and radiation. The role of each modality is discussed as well as current and futur …
Although optic pathway gliomas are low-grade tumors, their behavior can be aggressive, and their management is often challenging. Their mana …
Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review.
Shlobin NA, Montgomery EY, Mohammad LM, Kandula V, Beestrum M, DeCuypere M, Lam SK. Shlobin NA, et al. World Neurosurg. 2022 Aug;164:436-449.e2. doi: 10.1016/j.wneu.2022.04.033. Epub 2022 Apr 14. World Neurosurg. 2022. PMID: 35430402 Review.
Of surgical studies, 62.5% (5/8) indicated deterioration, and 37/5% (3/8) indicated no change. The singular study examining observation reported deterioration in visual outcomes. Factors associated with poor visual outcomes included signs and symptoms of visual decline at …
Of surgical studies, 62.5% (5/8) indicated deterioration, and 37/5% (3/8) indicated no change. The singular study examining observation …
Acute angle plication of optic nerve glioma as a mechanism of rapidly progressive visual loss.
Tooley AA, Rasool N, Campbell A, Kazim M. Tooley AA, et al. Orbit. 2021 Feb;40(1):30-33. doi: 10.1080/01676830.2020.1733027. Epub 2020 Feb 24. Orbit. 2021. PMID: 32093512
The purpose of this study was to determine anatomic differences of ONG noted either by imaging or by intra-operative observation between patients with gradual visual dysfunction and those with rapid visual loss. ...
The purpose of this study was to determine anatomic differences of ONG noted either by imaging or by intra-operative observation betw …
142 results